![]() |
Sign in to view your progression
|
Dear Professor, Dear Doctor,
It is with great pleasure that the Alliance Bristol Myers Squibb and Pfizer invite you to watch the e-learning :
Atrial Fibrillation: rebooting anticoagulation priorities and management
During this e-learning, Professor John Camm (St George's Unversity of London) will summarize the most important data about patients suffering of atrial fibrillation with additional comorbidities and how to manage their risk of stroke and bleeding. In addition, Professor Hein Heidbuchel (Antwerp University Hospital, Belgium) will present 4 specific and challenging patient cases, guiding us through the appropriate treatment options to consider.
This e-learning, recorded on 24/05/2022, is split into 5 modules to be viewed at your own pace.
- Module 1 : Main learnings of pivotal trials and importance of GI bleeding (duration : 13 min.)
- Module 2 : The elderly patient with AF (duration : 6 min.)
- Module 3 : AF patients with CKD and/or diabetes (duration : 19 min.)
- Module 4 : Adherence and appropriate dosage (duration : 4 min.)
- Module 5 : Patient Cases (duration : 15 min.)
We hope you will find this non-accredited e-learning useful for your daily practice.
If you encounter technical issue to watch the e-learning, please contact the technical team via support@multilearning.com
After this e-learning the participant will be able to :
- deal with general results in the world of anticoagulation
- manage AF patients with a more specific profile
Theses e-learning sessions are available for :
- Cardiologists
- Geriatricians
- Neurologists
- Internal medicine
MODULE 1 - Main learnings of pivotal trials and importance of GI bleeding (duration : 13 min.)
|
|
MODULE 2 - The elderly patient with AF (duration : 6 min.)
|
|
MODULE 3 - AF patients with CKD and/or diabetes (duration : 19 min.)
|
|
MODULE 4 - Adherence and appropriate dosage (duration : 4 min.)
|
|
MODULE 5 - Patient Cases (duration : 15 min.)
|
|